Board of Directors

Susanne Olauson

Acting Chairman of the Board, since 2024, Member of the Board, since 2013

Professional background
Susanne has over 25 years of sales experience in the pharmaceutical industry, the medical technology industry, and life science. This includes positions as VP of Commercial Operations, European Congress Manager, Director of Sales & Marketing Development and Product Specialist.

Education
Bachelor in Marketing from Växjö University.

Other assignments
Chairman of the Board at Odinwell AB (publ.), board member of LiU invest AB, Red one & Red two AB.

Shares in Redsense Medical
13 000 shares

Non independent
As a major owner in Patrik Byhmer’s estate, Susanne is the second largest shareholder and therefor non-independent.

Martin Roos

Member of the Board, since 2024

Professional background
Martin Roos is an INSEAD certified board director (IDP) with board and executive experience from telecom, tech and biotech. Previously Martin has served on the Board Operating Committee of WOM in Chile, and was the CEO for Cable and Wireless Caribbean and Altice in the Dominican Republic (integrating Orange with Tricom), in addition to senior leadership positions with Ericsson. During his tenure at Cable and Wireless, Martin also served on the Board of Directors of TSTT in Trinidad and Tobago.

Education
Master in Economics from Stockholm School of Economics. Master in Chemical Engineering from The Royal Institute of Technology in Stockholm.

Other assignments
Chairman for Seamless Distribution Systems AB and INDIVD AB, and board member of Nexam Chemical Holding AB, Lignin Industries AB, Codiqo AB, Spiffbet AB, Medclair AB, The Path Less Travelled AB.

Shares in Redsense Medical
14 500 shares

Independent
Independent in relations to the Company, its management and the larger shareholders.

Johannes Köpple

Member of the Board, since 2025

Professional background

Johannes leads ShapeQ GmbH and its associated companies. The ShapeQ Group,
currently the largest shareholder in Redsense Medical, aims to invest patiently and provide long-term capital in tomorrow’s most promising scale-ups. Before joining ShapeQ, he was co-manager of a European SME equity fund. During his years at the helm of the investment fund, he led several investments in transformational business projects with great success and developed an extensive network among business leaders in Europe.

Education
Master in international Finance form Nürtingen-Geislingen University.

Other assignments
Board member of Flowsparks N.V. and Snam Group.

Shares in Redsense Medical
no shareholding

Mike Griffiths

Member of the Board, since 2025

Professional background
Mike Griffiths has been co-founder and CEO of AOTI since 2006. He has more than 35 years of international experience in management roles in the medical device industry, including both start-up and senior management roles in multinational companies. Prior to AOTI, he co-founded and was a member of the management team of eVent Medical Ltd, which was later acquired by Kobayashi Pharmaceutical Corporation in Japan. Prior to that, Mike Griffiths also held senior roles at Mallinckrodt Inc, Nellcor Puritan Bennett Inc, Hudson RCI and Puritan Bennet Inc. He is also a Fellow of the Royal Society of Medicine and Chartered Management Institute in the UK.

Education
Mike holds a PhD in Medical Device Innovation from Middlesex University in London, UK, and a PhD in Management from Kingston University in London, UK.

Other assignments
Co-founder and CEO of AOTI, and a director of Advanced Oxygen Therapy Inc and two of its subsidiaries, Lanai Owners Association and Nexa Medical Limited. He is also the Chairman of the International Bipolar Foundation, which advocates for mental health equality and provides support to those living with bipolar disorder, as well as their family members

Shares in Redsense Medical
no shareholding